Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
other · US Department of Health and Human Services · Rule · Published 2025-02-19 · Effective 2025-03-21 · 90 FR 9841
Document
Document number
2025-02793
Federal Register citation
90 FR 9841
CFR reference
21 CFR 1306
Type
Rule
Action
Final rule; delay of effective dates and request for comments.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
2025-02-19
Effective date
2025-03-21
HHS docket
Docket No. DEA-948
Abstract
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services are delaying the effective dates of these two final rules to March 21, 2025, and are soliciting public comments specifically regarding this delayed effective date.